Gantofiban
- Level
- Commodity
- Parent
- 51131700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51131726This classification denotes a thrombolytic agent with the molecular formula C21H29N5O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MRG9KH7HF6, chemically known as 4-(((5r)-3-(p-(carboxyamidino)phenyl)-2-oxo-5-oxazolidinyl)methyl)-1-piperazineacetic acid, 1-ethyl methyl ester. but generally known as gantofiban, which bears US NIH Compound Identifier 9578736. The term GANTOFIBAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). Most nations schedule gantofiban under HS 29349990 and SITC 51579. As of Q4 2014, GANTOFIBAN remains the US FDA Preferred Term for this commodity. Gantofiban bears US NLM identifiers UMLS ID C1120900 and NCI Concept Code C73227. SMILES: CCCOC(=O)CN1CCN(CC1)CC2CN(C(=O)O2)C3=CC=C(C=C3)C(=NC(=O)O)N.
Same parent
Under 51131700 · 48Activities that produce or sell this
KBLI · 8Inherited from family 51130000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.